Autologous cytokine-induced killer cell adoptive immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous cytokine-induced killer cell adoptive immunotherapy, covering 2017-02-10 to 2017-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome [Phase 1, Phase 2]